Stroke thrombolysis: We need new data, not more reviews

Lancet Neurology

Volumn 4, Issue 4, 2005, Pages 204-205

  Hoffman, Jerome R ^a   Cooper, Richelle J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE;

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CALCULATION; CLINICAL TRIAL; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; FIBRINOLYTIC THERAPY; HUMAN; MEDICAL ETHICS; MEDICAL INFORMATION; METHODOLOGY; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PATIENT; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STROKE; SYMPTOM; TIME; VALIDATION PROCESS;

EID: 15044349793     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(05)70025-9     Document Type: Letter

References (17)

1. JR Hoffman Should physicians give tPA to patients with acute ischemic stroke? And just what is the emperor of stroke wearing? West J Med 173 2000 149 150
2. IL Katzan, AJ Furlan, LE Lloyd Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience JAMA 283 2000 1151 1158
3. DM Bravata, N Kim, J Concato, HM Krumholz, LM Brass Thrombolysis for acute stroke in routine clinical practice Arch Intern Med 162 2002 1994 2001
4. RI Lindley, JM Wardlaw, PG Sandercock Stroke thrombolysis: have new reviews of old data helped? Lancet Neurol 4 2005 249 253
5. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
6. TJ Ingall, WM O'Fallon, K Asplund Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial Stroke 35 2004 2418 2424
7. JR Hoffman Tissue plasminogen activator (tPA) for acute ischaemic stroke: Why has so much been made of so little Med J Aust 179 2003 333 334
8. JR Marler, BC Tilley, M Lu Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study Neurology 55 2000 1649 1655
9. W Hacke, G Donnan, C Fieschi Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials Lancet 363 2004 768 774
10. Multicentre Acute Stroke Trial - Italy (MAST-I) Group Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke Lancet 346 1995 1509 1514
11. The Multicentre Acute Stroke Trial - Europe Study Group Thrombolytic therapy with streptokinase in acute ischemic stroke N Engl J Med 335 1996 145 150
12. G Donnan, SM Davis, BR Chambers Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group JAMA 276 1996 961 966
13. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction Lancet 339 1992 753 770
14. The International Study Group In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin Lancet 336 1990 71 75
15. The GUSTO investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
16. PM Ridker, CJ O'Donnell, VJ Marder, CH Hennekens A response to "Holding GUSTO up to the light" Ann Intern Med 120 1994 882 885
17. ME Farkouh, JD Lang, DL Sackett Thrombolytic agents: the science of the art of choosing the better treatment Ann Intern Med 120 1994 886 888